- Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?
Paulo Alexandre Ribeiro Mora et al, 2019, Gynecologic Oncology CrossRef - Management of trophoblastic tumors : review of evidence, current practice, and future directions
Antoine Deleuze et al, 2023, Expert Review of Anticancer Therapy CrossRef - Current chemotherapeutic options for the treatment of gestational trophoblastic disease
Antonio Braga et al, 2023, Expert Opinion on Pharmacotherapy CrossRef - Case report: Multidrug resistant gestational trophoblastic neoplasia: focus on failure of immunotherapy and success of high-dose chemotherapy
Anne Enuset et al, 2024, Frontiers in Oncology CrossRef - High-Risk Gestational Trophoblastic Neoplasia
K. Kalaichelvi, 2021, Gestational Trophoblastic Disease CrossRef - Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Nadeem R. Abu-Rustum et al, 2019, Journal of the National Comprehensive Cancer Network CrossRef - Influence of cord blood serum and actovegin on the reproductive function of cows in the comparative aspect
Irina Bondarenko et al, 2021, EUREKA: Health Sciences CrossRef - The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia
M.M. Frijstein et al, 2019, European Journal of Cancer CrossRef - Epidemiologic study on gestational trophoblastic diseases in Japan
Eiko Yamamoto et al, 2022, Journal of Gynecologic Oncology CrossRef - The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia
Shizuka Sato et al, 2020, International Journal of Clinical Oncology CrossRef - A case of complete remission of intractable gestational choriocarcinoma with subsequent chemotherapy after pembrolizumab
Kaoru Niimi et al, 2023, Taiwanese Journal of Obstetrics and Gynecology CrossRef - Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN)
Giorgia Mangili et al, 2022, Cancers CrossRef